Clinical Trials Sponsored by Quadras Scientific Solutions

Total 11 results

Quadras Scientific Solutions

Completed

A Single-Dose,ComparativeBioavailability Study ofTwo Formulations ofErlotinib150mgTabletsunderFastingConditions

Lung Cancer
Biohope Scientific Solutions for Human Health,...

Completed

Evaluation of Immunobiogram® as a Tool in Adjustment of Immunosuppressant Therapy for Renal Transplant (TRANSBIO)

Kidney Transplantation

United States
Biohope Scientific Solutions for Human Health,...

Recruiting

BIOtechnology Applied to Renal TRansplantation With IMmunobiogram (BIOTRAIM)

Kidney Transplant Failure and Rejection

Spain, Germany, Sweden, Brazil, France
Boston Scientific Corporation
Pharmaceutical Research Associates; Medidata Solutions

Completed

PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study (PE-Prove)

Coronary Heart Disease

Spain, Ireland, Denmark, United Kingdom, Belgium, Germany, France, Netherlands, Italy, Austria, Hungary
University of Pittsburgh
EndoGastric Solutions; Sandhill Scientific; Crospon

Terminated

Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment (TvP)

Gastroesophageal Reflux Disease (GERD)

Netherlands
Heart Rhythm Clinical and Research Solutions, LLC
Boston Scientific Corporation

Not yet recruiting

A Registry Based Collaborative to Measure Efficiency, Effectiveness, and Safety of Farapulse PFA Technology for AF (DISRUPT-AF)

Atrial Fibrillation

United States
Boston Scientific Corporation
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; CRO genae; Medidata Solutions

Completed

Adapt Monorail Carotid Stent System: A Postmarket Clinical Follow-up Study (ASTI)

Stroke | Carotid Stenosis | Carotid Artery Disease

Germany, Belgium, Spain
Boston Scientific Corporation
Beth Israel Deaconess Medical Center; Quintiles, Inc.; Medstar Health Research... and other collaborators

Completed

EVOLVE II QCA: A Prospective, Multicenter Trial to Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s) (EVOLVE II QCA)

Atherosclerotic Lesion(s)

New Zealand, Singapore, Australia, Japan
Eli Lilly and Company
University of Colorado, Denver; Quintiles, Inc.; PPD; Parexel; Laboratory Corporation... and other collaborators

Completed

First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin (INSPIRE)

Non Small Cell Lung Cancer

Belgium, Brazil, Russian Federation, United Kingdom, Australia, Germany, Hungary, Italy, Romania, United States, Austria, Canada, Croatia, France, Greece, Poland, Portugal, Slovakia, South Africa, Spain
Eli Lilly and Company
University of Colorado, Denver; PPD; Parexel; ICON Clinical Research; Laboratory... and other collaborators

Active, not recruiting

First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin (SQUIRE)

Non Small Cell Lung Cancer

United States, Belgium, Brazil, Russian Federation, Serbia, Spain, United Kingdom, Germany, Australia, Hungary, Italy, Romania, Austria, Croatia, France, Greece, Poland, Portugal, Slovakia, South Africa, Philippines, Canada, Korea,... and more
AstraZeneca
Laboratory Corporation of America; Medidata Solutions; IQVIA RDS Inc.; Calyx; Thermo... and other collaborators

Recruiting

Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis. (EE)

Erosive Esophagitis

United States, Italy, Belgium, Vietnam, Spain, Portugal, Russian Federation, Argentina, Greece, Australia, Lithuania

Clinical Trials Sponsored by Quadras Scientific Solutions

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations